Literature DB >> 15925402

The role of the cannabinoid system in nicotine addiction.

Anna Castañé1, Fernando Berrendero, Rafael Maldonado.   

Abstract

Nicotine, the main psychoactive component in tobacco smoke, appears to play a major role in tobacco addiction, producing a high morbidity and mortality in the world. A great amount of research has been developed to elucidate the neural pathways and neurotransmitter systems involved in such a complex addictive behaviour. One possible candidate is the cannabinoid system, which has been reported to participate in the addictive properties of other drugs of abuse. This review is focused on the recent pharmacological and molecular studies assessing cannabinoid-nicotine interactions, with special attention to those studies evaluating the behavioural responses related to the development of nicotine addiction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15925402     DOI: 10.1016/j.pbb.2005.01.025

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  35 in total

Review 1.  Tobacco addiction and the dysregulation of brain stress systems.

Authors:  Adrie W Bruijnzeel
Journal:  Neurosci Biobehav Rev       Date:  2012-03-03       Impact factor: 8.989

2.  Inhibition of monoacylglycerol lipase reduces nicotine reward in the conditioned place preference test in male mice.

Authors:  Pretal P Muldoon; Lois S Akinola; Joel E Schlosburg; Aron H Lichtman; Laura J Sim-Selley; Anu Mahadevan; Benjamin F Cravatt; M Imad Damaj
Journal:  Neuropharmacology       Date:  2020-05-30       Impact factor: 5.250

3.  A reliable model of intravenous MDMA self-administration in naïve mice.

Authors:  José Manuel Trigo; Fany Panayi; Guadalupe Soria; Rafael Maldonado; Patricia Robledo
Journal:  Psychopharmacology (Berl)       Date:  2005-12-15       Impact factor: 4.530

4.  Fatty acid amide hydrolase (FAAH) inactivation confers enhanced sensitivity to nicotine-induced dopamine release in the mouse nucleus accumbens.

Authors:  Francisco J Pavon; Antonia Serrano; Nimish Sidhpura; Ilham Polis; David Stouffer; Fernando Rodriguez de Fonseca; Benjamin F Cravatt; Rémi Martin-Fardon; Loren H Parsons
Journal:  Addict Biol       Date:  2017-06-29       Impact factor: 4.280

5.  The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice.

Authors:  Bogna M Ignatowska-Jankowska; Pretal P Muldoon; Aron H Lichtman; M Imad Damaj
Journal:  Psychopharmacology (Berl)       Date:  2013-05-08       Impact factor: 4.530

6.  Inhibition of monoacylglycerol lipase reduces nicotine withdrawal.

Authors:  P P Muldoon; J Chen; J L Harenza; R A Abdullah; L J Sim-Selley; B F Cravatt; M F Miles; X Chen; A H Lichtman; M I Damaj
Journal:  Br J Pharmacol       Date:  2015-02       Impact factor: 8.739

Review 7.  Symbiotic relationship of pharmacogenetics and drugs of abuse.

Authors:  Joni L Rutter
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

8.  Treatment models for targeting tobacco use during treatment for cannabis use disorder: case series.

Authors:  Dustin C Lee; Alan J Budney; Mary F Brunette; John R Hughes; Jean-Francois Etter; Catherine Stanger
Journal:  Addict Behav       Date:  2014-04-13       Impact factor: 3.913

9.  The endogenous cannabinoid system modulates nicotine reward and dependence.

Authors:  Lisa L Merritt; B R Martin; C Walters; A H Lichtman; M Imad Damaj
Journal:  J Pharmacol Exp Ther       Date:  2008-05-01       Impact factor: 4.030

10.  Investigation of endocannabinoid modulation of conditioned responding evoked by a nicotine CS and the Pavlovian stimulus effects of CP 55,940 in adult male rats.

Authors:  Jennifer E Murray; Nicole R Wells; George D Lyford; Rick A Bevins
Journal:  Psychopharmacology (Berl)       Date:  2009-06-04       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.